Marran H. Ogilvie - May 29, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
May 29, 2023
Transactions value $
$0
Form type
4
Date filed
6/1/2023, 06:13 PM
Previous filing
Jun 1, 2023
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Award $0 +78.9K $0.00 78.9K May 29, 2023 Common Stock 78.9K Direct F1, F2, F3, F4
transaction AXDX Employee Restricted Stock Units Award $0 +237K $0.00 237K May 29, 2023 Common Stock 237K Direct F1, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served.
F3 Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following her departure from the issuer's board of directors.
F4 Not applicable.
F5 On May 29, 2023, the reporting person was granted RSUs which vest each year for 5 years, with the first installment vesting on May 29, 2024.